SMS Pharmaceuticals Ltd
₹385.20
(-1.08%)
Tue, 03 Mar 2026, 11:22 pm
Health Technology
Pharmaceuticals: Major
24.5KSMS Pharmaceuticals Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
3464.66
Net Profit
67.40
P/B
3.02
Sector P/E
32.50
P/E
27.27
EV/EBITDA
14.84
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.20
ROCE (Industry)
20.50
RONW (Industry)
17.60
ROE
11.46
ROCE
12.53
Debt/Equity
0.50
EPS (TTM)
9.57
Dividend Yield
0.10
Book Value
77.88
Interest Cover
5.98
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (14.9x coverage).
- SMS Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- SMS Pharmaceuticals is profitable, therefore cash runway is not a concern.
- SMS Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- SMS Pharmaceuticals's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- SMS Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- SMS Pharmaceuticals's level of debt (45.3%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 68.07 | 68.07 | 66.26 | 66.26 | 64.67 |
| FII | 0.04 | 0.28 | 0.03 | 0.08 | 0.31 |
| DII | 3.21 | 2.88 | 3.03 | 2.43 | 2.55 |
| Public | 28.69 | 28.78 | 30.67 | 31.22 | 32.47 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 557.65 | 461.30 | 423.25 | 364.95 | 326.90 | 268.60 | 172.25 |
| Fibonacci | 461.30 | 424.49 | 401.76 | 364.95 | 328.14 | 305.41 | 268.60 |
| Camarilla | 411.70 | 402.86 | 394.03 | 364.95 | 376.37 | 367.54 | 358.70 |
Pivots Level: Classic
R3
+192.70
557.65
R2
+96.35
461.30
R1
+58.30
423.25
S1
-38.05
326.90
S2
-96.35
268.60
S3
-192.70
172.25
Moving Average
Period
Value
10-EMA
370.98
20-EMA
357.13
30-EMA
348.09
50-EMA
336.27
100-EMA
316.36
200-EMA
292.26
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 07 Feb 2026 | board-meetings | Quarterly Results | |
| 08 Nov 2025 | board-meetings | Quarterly Results | |
| 22 Aug 2025 | dividend | Final Dividend - Rs. - 0.4 | 22 Sept 2025 |
| 09 Aug 2025 | agm | ||
| 30 May 2025 | dividend | ₹0.40 Dividend /Share | 22 Sept 2025 |
| 23 Aug 2024 | agm | Annual General Meeting | 24 Sept 2024 |
| 23 Aug 2024 | dividend | Final Dividend - Rs. - 0.4 | 23 Sept 2024 |
| 05 Aug 2024 | agm | ||
| 29 May 2024 | dividend | ₹0.40 Dividend /Share | 23 Sept 2024 |
| 13 Feb 2024 | egm |
Peer Comparison
SMS Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
SMS Pharmaceuticals Ltd About
SMS Pharmaceuticals is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1987
Headquarters
CEO
P Ramesh Babu
Employees
Contact
Website
http://www.smspharma.com
cs@smspharma.com; complianceofficer@smspharma.com;
Phone
91-40-66288888
Location
19 III Rd 71 Opp Bharatividya, Bhavan Public Sch Jubilee Hill, Hyderabad, Telangana, 500096
SMS Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2017 |
|
| 2018 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| MUSIGMA SECURITIES | Buy | 502320 | 317.12 | 26 Nov 2025 |
| MUSIGMA SECURITIES | Sell | 502320 | 317.44 | 26 Nov 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 679941 | 298.91 | 11 Sept 2025 |
| MUSIGMA SECURITIES | Sell | 719451 | 303.35 | 11 Sept 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 679941 | 298.44 | 11 Sept 2025 |
| MUSIGMA SECURITIES | Buy | 719451 | 302.98 | 11 Sept 2025 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Sell | 656793 | 302.79 | 11 Sept 2025 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Buy | 656793 | 302.55 | 11 Sept 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 658134 | 378.38 | 11 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 658134 | 377.83 | 11 Sept 2024 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800